Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation

被引:148
作者
Dehnad, H
Nederveen, AJ
van der Heide, UA
van Moorselaar, RJA
Hofman, P
Lagendijk, JJW
机构
[1] Univ Utrecht, Med Ctr, Dept Radiotherapy, NL-3584 CX Utrecht, Netherlands
[2] Univ Utrecht, Med Ctr, Dept Urol, NL-3584 CX Utrecht, Netherlands
关键词
gold markers; position verification; feasibility study; migration; prostate deformation;
D O I
10.1016/S0167-8140(03)00078-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: The aim of this study was to assess the feasibility of using gold seed implants in the prostate for position verification. using an a-Si flat panel imager as a detector during megavoltage irradiation of prostate carcinoma. This is a study to guarantee positioning accuracy in intensity-modulated radiotherapy. Methods and materials: Ten patients with localized prostate carcinoma (T2-3) received between one and three fiducial gold markers in the prostate. All patients were treated with 3-D conformal radiotherapy with an anterior-posterior (AP) and two lateral wedge fields. The acute gastrointestinal (GI) and genitourinary (GU) toxicities were scored using common toxicity criteria scales (CTC). Using three consecutive CT scans and portal images obtained during the treatment we have studied the occurrence of any change in prostate shape (deformation), seed migration and the magnitude of translations and rotations of the prostate. Results: We observed no acute major complications for prostate irradiation regarding the seed implantation. The maximum acute GU toxicity grade 2 (dysuria and frequency) was observed in seven patients during the treatment. The maximum grade 2 (diarrhoea) was scored in two patients regarding the acute GI toxicities. No significant prostate deformation could be detected in the consecutive CT scans. It appeared that the distances between the markers only slightly changed during treatment (S.D. 0.5 mm). Random prostate translations were (I S.D.) 2.1. 3.2 and 2.2 mm, in the lateral (LR), AP and cranial-caudal (CC) directions, respectively, whereas systematic translations were 3.3, 4.8 and 3.5 mm in the LR, AP and CC directions, respectively. Random prostate rotations were (I S.D.) 3.6, 1.7 and 1.9degrees around the LR, AP and CC axis, respectively, whereas systematic rotations were 4.7, 2.0 and 2.7degrees around the LR, AP and CC axis, respectively. Conclusions: We found that the fiducial gold seeds are a safe and appropriate device to verify and correct the position of prostate during megavoltage irradiation. The amount of seed migration and prostate deformation is far below our present tumour delineation accuracy. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:295 / 302
页数:8
相关论文
共 24 条
  • [1] [Anonymous], 1999, COMM TOX CRIT VERS 2
  • [2] Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study
    Aron, M
    Rajeev, TP
    Gupta, NP
    [J]. BJU INTERNATIONAL, 2000, 85 (06) : 682 - 685
  • [3] Automated localization of the prostate at the time of treatment using implanted radiopaque markers: Technical feasibility
    Balter, JM
    Lam, KL
    Sandler, HM
    Littles, JF
    Bree, RL
    TenHaken, RK
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 33 (05): : 1281 - 1286
  • [4] Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms
    Boersma, LJ
    van den Brink, M
    Bruce, AM
    Shouman, T
    Gras, L
    te Velde, A
    Lebesque, JV
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (01): : 83 - 92
  • [5] Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: A strategy for large-scale implementation for the treatment of carcinoma of the prostate
    Burman, C
    Chui, CS
    Kutcher, G
    Leibel, S
    Zelefsky, M
    LoSasso, T
    Spirou, S
    Wu, QW
    Yang, J
    Stein, J
    Mohan, R
    Fuks, Z
    Ling, CC
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (04): : 863 - 873
  • [6] PROSTATE MOTION DURING STANDARD RADIOTHERAPY AS ASSESSED BY FIDUCIAL MARKERS
    CROOK, JM
    RAYMOND, Y
    SALHANI, D
    YANG, H
    ESCHE, B
    [J]. RADIOTHERAPY AND ONCOLOGY, 1995, 37 (01) : 35 - 42
  • [7] GALL KP, 1993, MED PHYS, V20, P1153, DOI 10.1118/1.596969
  • [8] Organ motion and its management
    Langen, KM
    Jones, DTL
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (01): : 265 - 278
  • [9] Daily prostate targeting using implanted radiopaque markers
    Litzenberg, D
    Dawson, LA
    Sandler, H
    Sanda, MG
    McShan, D
    Ten Haken, RK
    Lam, KL
    Brock, KK
    Balter, JM
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (03): : 699 - 703
  • [10] Measurements and clinical consequences of prostate motion during a radiotherapy fraction
    Nederveen, AJ
    van der Heide, UA
    Dehnad, H
    van Moorselaar, RJA
    Hofman, P
    Lagendijk, JJW
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (01): : 206 - 214